Clinical Trial Update: Iloprost in High Risk Cardiac Surgical Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating iloprost in high-risk cardiac surgical patients with pulmonary hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension

Drugs mentioned

• Iloprost (iloprost)

Snippet

Sponsor: Ludwig-Maximilians - University of Munich | Conditions: Pulmonary Hypertension | Phase 3 | Status: COMPLETED